###begin article-title 0
###xml 44 49 <span type="species:ncbi:9606">Human</span>
###xml 120 124 <span type="species:ncbi:10090">Mice</span>
Colorectal Hyperplasia and Dysplasia Due to Human Carcinoembryonic Antigen (CEA) Family Member Expression in Transgenic Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: CC PC CS. Performed the experiments: CC PC. Analyzed the data: CC PC. Wrote the paper: CC PC CS.
###end p 1
###begin p 2
###xml 176 184 176 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 363 378 <span type="species:ncbi:10090">transgenic mice</span>
###xml 403 408 <span type="species:ncbi:9606">human</span>
###xml 606 611 <span type="species:ncbi:9606">human</span>
###xml 955 970 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1222 1227 <span type="species:ncbi:9606">human</span>
CEA and CEACAM6 are immunoglobulin family intercellular adhesion molecules that are up-regulated without structural mutations in approximately 70% of human cancers. Results in in vitro systems showing tumorigenic effects for these molecules suggest that this correlation could indicate an instrumental role in tumorigenesis. To test whether this applies in vivo, transgenic mice harboring 187 kb of the human genome containing four CEA family member genes including the CEA and CEACAM6 genes were created and their copy numbers increased by mating until colonocyte expression levels reached levels seen in human colorectal carcinomas. The colonocyte surface level of integrin alpha5 and the activation of AKT increased progressively with the expression levels of CEA/CEACAM6. Colonic crypts showed a progressive increase in colonocyte proliferation, an increase in crypt fission, and a strong inhibition of both differentiation and anoikis/apoptosis. All transgenic mice showed massively enlarged colons comprising a continuous mosaic of severe hyperplasia, dysplasia and serrated adenomatous morphology. These results suggest that up-regulated non-mutated adhesion molecules could have a significant instrumental role in human cancer.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Hammarstrom1">[1]</xref>
###xml 345 348 345 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Hammarstrom1">[1]</xref>
###xml 349 352 349 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Scholzel1">[4]</xref>
###xml 450 453 450 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ballesta1">[5]</xref>
###xml 454 457 454 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Jantscheff1">[7]</xref>
###xml 552 555 552 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Hammarstrom1">[1]</xref>
###xml 1022 1025 1022 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Scholzel1">[4]</xref>
###xml 1027 1030 1027 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ilantzis1">[8]</xref>
###xml 1071 1079 1071 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1244 1249 1244 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">prior</italic>
###xml 1297 1300 1297 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Eidelman1">[9]</xref>
###xml 1301 1305 1301 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Rojas1">[11]</xref>
###xml 1363 1367 1363 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ilantzis2">[10]</xref>
###xml 1403 1407 1403 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Duxbury1">[12]</xref>
###xml 1408 1412 1408 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ordonez1">[15]</xref>
###xml 1525 1529 1525 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Screaton1">[16]</xref>
###xml 1576 1580 1576 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ilantzis2">[10]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 289 294 <span type="species:ncbi:9606">human</span>
###xml 1100 1105 <span type="species:ncbi:9606">human</span>
###xml 1508 1511 <span type="species:ncbi:10116">rat</span>
###xml 1552 1557 <span type="species:ncbi:9606">human</span>
###xml 1699 1708 <span type="species:ncbi:10090">nude mice</span>
The human CEA family of cell surface intercellular adhesion molecules, a sub-family of the Immunoglobulin Superfamily, consists of both glyco-phosphatidylinositol (GPI) and transmembrane (TM) anchored members [1]. GPI-anchored members, CEA and CEACAM6, show up-regulation in 50-70% of all human cancers, including colon, breast and lung cancers [1]-[4]. In fact, CEA represents a major tumor marker used widely in the management of colorectal cancer [5]-[7]. The TM-anchored member, CEACAM1, on the other hand, usually shows down-regulation in cancers [1]. The question arises as to whether or not the positive correlation between CEA/CEACAM6 levels and tumors points to an instrumental role for these molecules in cancer. This question has significance for the clinical interpretation of CEA and CEACAM6 levels in tumors and for the development of CEA-targeted therapies. In spite of the fact that CEA and CEACAM6 are normally up-regulated as differentiation proceeds during the movement of colonocytes up colonic crypts [4], [8], experiments with various model systems in vitro, including cultured human colorectal carcinoma colonocytes, have shown that if CEA and/or CEACAM6 are inappropriately up-regulated in cells with division potential prior to differentiation, differentiation is blocked [9]-[11], cell polarization and tissue architecture are disrupted [10] and anoikis/apoptosis is inhibited [12]-[15]. All of the above effects can contribute to tumorigenicity and, in fact, ectopic expression in rat L6 myoblasts [16] or over-expression in human Caco2 colonocytes [10] of CEA and/or CEACAM6 prior to differentiation leads to a marked decrease in the latent period for tumor formation in nude mice.
###end p 4
###begin p 5
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Screaton2">[17]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Taheri1">[18]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Nicholson1">[19]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Taheri1">[18]</xref>
###xml 961 965 954 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Giancotti1">[20]</xref>
###xml 1173 1177 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-CamachoLeal1">[21]</xref>
###xml 1377 1381 1363 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Duxbury2">[22]</xref>
###xml 1568 1572 1554 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Stupack1">[23]</xref>
###xml 1573 1577 1559 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Guo1">[25]</xref>
The molecular mechanism for the observed tumorigenic effects of CEA and CEACAM6 could provide insight in considering this question. The structural requirements for CEA's differentiation-blocking ability have been shown to be self-associating external domains linked to a CEA-specific GPI anchor [17], the former to effect clustering and the latter to provide activation specificity following clustering [18], [19]. CEA occupies membrane microdomains (membrane rafts), which tend to cluster as the CEA cell surface density increases as it does in many cancers (see above). CEA external domain mutants deficient in self-binding have no effect on differentiation but become effective immediately after antibody-mediated cross-linking [18]. Thus, within 5 minutes after cross-linking, integrin alpha5beta1, a cell surface heterodimeric receptor affecting cell-extracellular matrix/cell-cell interactions involved in cell proliferation, differentiation and survival [20], becomes activated and co-localizes with CEA in larger membrane structures; rapid localization in low density membrane microdomains of ILK, AKT and MAPK and phosphorylation of AKT and MAPK are also observed [21], presumably because all of these elements occupy the same membrane rafts as CEA. Similarly, antibody-mediated cross-linking of CEACAM6 activates integrin alphavbeta3 in a pancreatic cancer cell line [22]. Integrin activation and subsequent activation of the PI3K/AKT and MAPK pathways have been reported by other groups to have the same effects observed here on differentiation and anoikis [23]-[25]. These results are thus consistent with the instrumental model of CEA and CEACAM6 in tumorigenesis.
###end p 5
###begin p 6
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 152 159 152 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Zimmermann1">[26]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-EadesPerner1">[27]</xref>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Clarke1">[28]</xref>
###xml 754 759 754 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Thompson1">[29]</xref>
###xml 288 303 <span type="species:ncbi:10090">transgenic mice</span>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 348 352 <span type="species:ncbi:10090">Mice</span>
###xml 424 429 <span type="species:ncbi:9606">human</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
###xml 615 621 <span type="species:ncbi:9606">humans</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 938 943 <span type="species:ncbi:9606">human</span>
The above results utilized various in vitro model systems involving CEA/CEACAM6 transfectants and could therefore have given findings that do not apply in vivo. To address this important caveat and to examine effects on tissue architecture in a valid setting, it was decided to construct transgenic mice containing human genes for CEA and CEACAM6. Mice do not possess GPI-anchored CEA family members, having only analogs of human TM-anchored CEACAM1 [26], making this experiment appropriate. Previous transgenics harboring the human CEA gene only, while showing the same pattern of tissue specific expression as in humans [27], [28], did not show a predilection for developing more tumors even when crossed with tumor susceptible mutant mice, such as APCMin/+ mice [29]. These mice, however, lacked CEACAM6 that is usually co-overexpressed with CEA in cancers, had transgene expression levels that could have been below those observed in human tumors and lacked upstream and downstream genomic sequences in their transgenes that could have been necessary for derangement of their expression, e.g., in colonocytes with division potential.
###end p 6
###begin p 7
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 672 676 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 1186 1193 1186 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 51 66 <span type="species:ncbi:10090">transgenic mice</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 348 353 <span type="species:ncbi:9606">human</span>
###xml 1071 1076 <span type="species:ncbi:9606">human</span>
###xml 1236 1241 <span type="species:ncbi:9606">human</span>
The above deficiencies were dealt with by creating transgenic mice containing a 187 kb insert from a bacterial artificial chromosome (BAC) that included the complete human genes for CEA, CEACAM6, CEACAM7 and CEACAM3 plus about 20-30 kb of both upstream and downstream sequences [30]. The expression patterns of these genes were almost identical to human patterns, showing normal expression of CEA and CEACAM6 in colorectal crypts with, unlike the CEA-only transgenics by Eades-Perner et al., the correct gradient, i.e., higher towards the upper ends of the crypts. They also showed very low colorectal cryptal expression of CEACAM7 and no colorectal expression of CEACAM3 [30]. Two independent transgenic founders were obtained with 2 and 10 head-to-tail copies of the transgene and colonic expression levels directly proportional to their copy number [30]. Higher copy transgenics were then derived by mating the 10 copy founders to give 20 copy homozygotes and a further 2-fold increase in colonic expression. The latter expression levels were in the range observed in human colorectal carcinomas. We were thus poised to look for possible tumorigenic effects of CEA and CEACAM6 in an in vivo system that more closely approximated the human situation.
###end p 7
###begin p 8
###xml 186 194 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 6 21 <span type="species:ncbi:10090">transgenic mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
These transgenic mice showed dramatic expression level-dependent tumorigenic effects: with some variation in detail, the same changes in integrin alpha5beta1, ILK and AKT as seen in the in vitro model systems were observed in purified colonocytes; furthermore, the mice showed inhibition of colonocyte differentiation (at least for the goblet cell lineage) and anoikis and disruption of tissue architecture characteristic of extreme hyperplasia and dysplasia.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 34 38 <span type="species:ncbi:10090">Mice</span>
Construction of CEABAC Transgenic Mice
###end title 10
###begin p 11
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 371 374 371 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Hammarstrom1">[1]</xref>
###xml 486 493 486 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 649 658 649 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g001">Figure 1A</xref>
###xml 793 797 793 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 905 914 905 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g001">Figure 1B</xref>
###xml 21 36 <span type="species:ncbi:10090">transgenic mice</span>
###xml 188 193 <span type="species:ncbi:9606">human</span>
###xml 364 370 <span type="species:ncbi:9606">humans</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
CEABAC2 and CEABAC10 transgenic mice are independent founders containing 2 and 10 head-to-tail copies, respectively, of the 187 kb genomic DNA insert of a BAC which includes the genes for human CEA, CEACAM6, CEACAM7 and CEACAM3 [30]. The tissue specific expression patterns for these genes have been documented previously [30] and are almost identical to those in humans [1]. CEABAC20 mice with 20 copies were obtained by mating CEABAC10 mice, which are heterozygous for the transgene. In situ hybridization with a fluorescein isothiocyanate (FITC)-labeled CEA cDNA probe of cell nuclei showed a single spot for CEABAC10 and two spots for CEABAC20 (Figure 1A), which is consistent with the previous molecular analysis of CEABAC10 indicating head-to-tail linkage of all copies into one complex [30]. The CEABAC20 mice could be immediately recognized in litters because of their significantly smaller size (Figure 1B), which could be attributed to impaired gastrointestinal function (see below).
###end p 11
###begin title 12
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Expression of CEA and CEACAM6 in the CEABAC mouse colon.
###end title 12
###begin p 13
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 570 575 <span type="species:ncbi:9606">human</span>
###xml 624 629 <span type="species:ncbi:10090">mouse</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
###xml 1058 1063 <span type="species:ncbi:9606">human</span>
###xml 1122 1127 <span type="species:ncbi:10090">mouse</span>
###xml 1217 1222 <span type="species:ncbi:9606">human</span>
A) Images of fluorescence in situ hybridization (FITC-labeled CEA cDNA probes and DAPI-stained nuclei) show one nuclear spot (red arrow) for CEABAC10 and two for CEABAC20. Magnification: 1000x. B) Significant reduction visually of body size of CEABAC20 mice at 3 weeks of age. C) Immunoblots of colon protein extracts show a correlation between expression levels of CEA (detected with A20 mAb) and CEACAM6 (detected with 9A6 mAb) and CEABAC transgene copy numbers in the CEABAC mice (CEABAC2, CEABAC10 and CEABAC20). D) Immunohistochemical staining (brown staining) for human CEACAM (detected with RbalphaCEA) in 3 week-old mouse colons shows increasing expression levels of CEA/CEACAM6 correlated with the transgene copy number. The high expression level of CEA/CEACAM6 in the CEABAC20 mice was no longer restricted to the apical surface (red arrow points to apical surface staining; black arrows point to basolateral staining) and significant intracellular localization of CEA/CEACAM6 was also evident. E) Immunohistochemical staining (brown staining) for human CEACAM (detected with RbalphaCEA) in 3 month-old CEABAC20 mouse colons shows levels and patterns of CEA/CEACAM6 expression which are similar to those of human colorectal carcinomas at a similar stage of progression. WT denotes wild-type littermate.
###end p 13
###begin p 14
###xml 97 106 97 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g001">Figure 1C</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
Immunoblot analysis for CEA and CEACAM6 expression in the colons of 3 month old mice is shown in Figure 1C. As expected, wild-type (WT) mice show no expression of these human CEACAM family members, whereas CEABAC2, CEABAC10 and CEABAC20 mice show increasing expression levels in direct proportion to their transgene copy number.
###end p 14
###begin p 15
###xml 713 722 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g001">Figure 1D</xref>
###xml 935 944 935 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g001">Figure 1D</xref>
###xml 1090 1099 1090 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g001">Figure 1E</xref>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 433 448 <span type="species:ncbi:10090">transgenic mice</span>
###xml 475 480 <span type="species:ncbi:9606">human</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 929 933 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1061 1066 <span type="species:ncbi:9606">human</span>
The spatial expression pattern, both qualitatively and quantitatively, was important to assess, if any of these mice were to serve as models for human colorectal carcinogenesis. Appropriately elevated expression levels in colonocytes in the proliferative zone of colonic crypts would be required for this. As an approximate estimate, immunohistochemistry for CEA/CEACAM6 was performed on colonic sections from 3 week and 3 month old transgenic mice and compared with that of human colorectal carcinomas at a common stage of progression. In concordance with the immunoblot analysis, CEABAC2, CEABAC10 and CEABAC20 mice showed increasing expression levels of CEA/CEACAM6 in the transgenic colons at 3 weeks of age (Figure 1D). However, the high expression level of CEA/CEACAM6 in the CEABAC20 mice was no longer restricted to the apical surface. Moreover, intracellular localization of CEA/CEACAM6 was more evident in the CEABAC20 mice (Figure 1D). By 3 months of age, the expression level and pattern of CEA/CEACAM6 in the CEABAC20 mice were similar to those of human colorectal carcinomas (Figure 1E).
###end p 15
###begin title 16
Molecular Changes in CEABAC Colonocytes
###end title 16
###begin p 17
###xml 130 138 123 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 152 164 145 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 508 517 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g002">Figure 2C</xref>
###xml 631 648 613 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g002">Figures 2A and 2B</xref>
###xml 956 965 934 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g002">Figure 2D</xref>
###xml 209 224 <span type="species:ncbi:10090">transgenic mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
###xml 1131 1146 <span type="species:ncbi:10090">transgenic mice</span>
A case for a positive change in the activation state of integrin alpha5beta1 as a result of CEA clustering was made from previous in vitro studies (see Introduction). Here, using purified colonocytes from the transgenic mice, it was not technically possible to measure their binding to fibronectin, the major ligand of integrin alpha5beta1, as an indication of its activation state. However, the cell surface level of integrin alpha5 was higher in CEABAC2 than in WT colonocytes and even higher in CEABAC10 (Figure 2C). This finding correlated well with the cell surface levels of CEA and CEACAM6 in the CEABAC2 and CEABAC10 mice (Figures 2A and 2B). CEABAC20 colonocytes were not included in this part of the characterization because the extensive distortion of the crypt architecture (see below) rendered their isolation too difficult using the current method. The expression level of integrin alpha2 showed no such increase with CEA/CEACAM6 expression (Figure 2D) and integrin alphav could not be detected (data not shown). These results suggest that integrin alpha5beta1 signaling could be increased in colonocytes from CEABAC transgenic mice and in a CEA/CEACAM6 gene dose-dependent fashion.
###end p 17
###begin title 18
Cell surface expression of CEACAM and integrins on purified colonocytes.
###end title 18
###begin p 19
FACS profiles of WT (shaded area), CEABAC2 (dotted line) and CEABAC10 (solid line) purified colonocytes. A-B) FACS profiles of CEA detected by T84.66 mAb (A) and CEACAM6 detected by 9A6 mAb (B), show a higher cell surface expression of CEA and CEACAM6 in the CEABAC10 than CEABAC2 colonocytes, whereas wild-type (WT) colonocytes show only a background flurorescence. C) FACS profiles of integrin alpha5 detected by HMalpha5-1 mAb show increasing cell surface expression levels of integrin alpha5 with increasing CEA/CEACAM6 cell surface expression levels (A-B). D) FACS profiles of integrin alpha2 detected by HMalpha2 mAb show the same cell surface or even less expression levels of integrins alpha2.
###end p 19
###begin p 20
###xml 319 332 315 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g003">Figure 3A &amp; C</xref>
###xml 388 396 384 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 405 409 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-CamachoLeal1">[21]</xref>
###xml 509 518 498 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g003">Figure 3A</xref>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
In agreement with the latter supposition, a shift in subcellular localization towards less dense membrane complexes typical of membrane rafts for integrin alpha5, ILK and AKT and an increase in phosphorylation for AKT were observed in purified colonocytes from CEABAC2 and CEABAC10 mice relative to WT littermate mice (Figure 3A & C), as was previously seen for these elements in various in vitro systems [21]. No such changes were observed for the integrin alpha2 subunit, the integrin beta1 subunit or FAK (Figure 3A). However, since the overall detection level of integrin beta1 (in contrast to integrin alpha2 and FAK) was very low and no visible signal was detected in the low-density membrane fractions, the failure to see a shift in the subcellular localization of integrin beta1 was questionable. In addition, the beta1 subunit is shared by many alpha subunits and so might not be expected to show large changes. Similarly, PI3K was undetectable in this experiment (data not shown).
###end p 20
###begin title 21
Subcellular localization of CEACAM and integrin signaling elements in purified colonocytes.
###end title 21
###begin p 22
###xml 1111 1112 1100 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1131 1132 1120 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 619 624 <span type="species:ncbi:10090">mouse</span>
A) Immunoblots of different membrane fractions of purified colonocytes derived from sucrose density gradients show a shift in subcellular localization from high density (H) towards low density (L) membrane complexes for integrin alpha5, ILK, total AKT and Ser473-phosphorylated AKT (pAKT) in purified colonocytes from CEABAC2 and CEABAC10 mice relative to WT littermate mice. No such shift was observed for integrin alpha2, integrin beta1 and FAK. GM1 is a marker for membrane raft-containing membrane fractions. Note that these immunoblots are representative of three independent experiments using at least 6 mice per mouse group. B) Antibody-mediated cross-linking of CEA and CEACAM6 with J22 mAb in the purified colonocytes accentuates the shift of ILK to the less dense membrane fractions shown in A. C) Densitometric analysis of immunoblots for AKT and pAKT shown in A. The mean densitometric ratios (the intensity of band in L divided by the one in H) from three independent experiments show a statistical significant shift of AKT and pAKT to the low density membrane complexes in the CEABAC colonocytes (P<0.001 for AKT and P<0.005 for pAKT). Error bars  =  SEM (N = 3).
###end p 22
###begin p 23
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-CamachoLeal1">[21]</xref>
###xml 370 379 370 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g003">Figure 3B</xref>
###xml 687 691 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Giancotti1">[20]</xref>
###xml 693 697 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Guo1">[25]</xref>
These increases were understandably less dramatic than those observed in vitro in which the events were synchronized by cross-linking cell surface mutant CEA molecules that lacked self-adhesive external domains [21]. Here, antibody-mediated cross-linking of CEA and CEACAM6 in the purified colonocytes accentuated the shift of ILK towards less dense membrane complexes (Figure 3B), which is consistent with the suggestion that they arose as a consequence of CEA/CEACAM6 clustering leading to integrin alpha5beta1 activation. Regardless of the verity of the latter interpretation, the results provide evidence for the activation of AKT, an acknowledged consequence of integrin activation [20], [25].
###end p 23
###begin title 24
Cellular Changes in CEABAC Colonocytes
###end title 24
###begin p 25
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 432 441 428 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g004">Figure 4B</xref>
###xml 626 635 622 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g004">Figure 4A</xref>
###xml 720 730 716 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g004">Figures 4A</xref>
###xml 735 737 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g005">5A</xref>
###xml 830 839 826 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g004">Figure 4C</xref>
###xml 898 902 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Mandir1">[31]</xref>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
What are the cellular consequences in vivo of the increase in cell surface density of integrin alpha5 and the consequent downstream molecular activation events that arise from the presence of the CEABAC transgenes in colonocytes? A transgene copy number-dependent increase in the colonocyte proliferation index indicated by PCNA staining was observed in colonic crypts from 3 week-old CEABAC transgenics relative to WT littermates (Figure 4B). This was due to the progressive extension (with CEABAC dose) of the proliferative zone towards the upper parts of the crypts reaching the full length of the crypts in CEABAC20 mice (Figure 4A). This effect resulted in an overall increase in the length of the CEABAC20 crypts (Figures 4A and 5A). There was also a marked CEABAC dose-dependent increase in the incidence of crypt fission (Figure 4C), the process whereby new crypts are created in the colon [31].
###end p 25
###begin title 26
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Hyperproliferation in CEABAC mouse colonic epithelium at 3 weeks of age.
###end title 26
###begin p 27
###xml 498 499 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 694 695 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
A) Extension of the proliferative zones in colonic crypts is shown for both CEABAC10 and CEABAC20 by PCNA staining. Lengthening of crypts, poor cryptal alignment, increase of peri-cryptal stroma, and elongation of nuclei are noted in CEABAC20 mice, indicating hyperplastic changes. Arrow shows an example of crypt fission used to calculate percent crypt fission for C. B) Proliferation indices estimated by PCNA staining in A show significant increases for both CEABAC10 and CEABAC20 from WT mice (P<0.0001). C) Percent crypt fission plotted against transgene copy-number shows a linear curve with a correlation coefficient of 0.977; each data point is significantly different from the others (P<0.0001). D) Cross sections of colons show increasing epithelial content with increasing CEABAC transgene copy number (i.e. CEA/CEACAM6 expression levels). Magnification: 400x (A), 100x (D). Staining: hematoxylin. Error bars represent standard errors of the mean (N = 9). WT denotes wild-type littermate.
###end p 27
###begin title 28
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Differentiation block in CEABAC mouse colonic epithelium at 3 weeks of age.
###end title 28
###begin p 29
###xml 711 712 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
A) Mucin staining of colonic crypts of WT, CEABAC2, CEABAC10, and CEABAC20 mice shows a progressively decreasing number of visible purplish-colored differentiated goblet cells (indicated by an arrow in the WT colonic crypt) correlated with increasing CEABAC transgene copy number. Lengthening of crypts, poor cryptal alignment, increase of peri-cryptal stroma, absence of bluish cytoplasm, abundance of small purplish mucinous vacuoles and elongation of nuclei are noted in CEABAC20 mice, indicating hyperplastic changes. Magnification: 400x. Staining: AB/PAS/MG. B) Number of normal-size goblet cells per crypt plotted against transgene copy-number; each data point is significantly different from the others (P<0.0001). 35%, 67% and 85% (95% after considering the 3-fold increase in crypt length) reductions relative to WT mice (i.e. 0 transgene copy) are obtained for CEABAC2, CEABAC10 and CEABAC20 mice, respectively. Error bars represent standard errors of the mean (N = 9). WT denotes wild-type littermate.
###end p 29
###begin p 30
###xml 176 184 176 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g005">Figure 5</xref>
###xml 267 275 267 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 284 287 284 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Eidelman1">[9]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Rojas1">[11]</xref>
###xml 159 174 <span type="species:ncbi:10090">transgenic mice</span>
Lastly, a strong CEABAC dose-dependent decrease in the differentiation of colonocytes, at least for the goblet cell lineage in the crypts, was observed in the transgenic mice (Figure 5), consistent with the pan-inhibition of cellular differentiation noted in various in vitro systems [9]-[11].
###end p 30
###begin title 31
Hyperplastic and Dysplastic Changes in CEABAC Colons
###end title 31
###begin p 32
###xml 199 208 199 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g004">Figure 4D</xref>
###xml 414 422 414 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g006">Figure 6</xref>
###xml 475 484 475 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g001">Figure 1B</xref>
###xml 182 197 <span type="species:ncbi:10090">transgenic mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
A progressive shift with CEABAC dose towards a deranged tissue architecture featuring more mucosal tissue and less luminal space was seen in cross sections of colons from 3 week-old transgenic mice (Figure 4D). This effect became quite dramatic in CEABAC20 mice by 3 months of age, where 100% of the mice showed grossly enlarged colons with crypts up to 10 times normal length and with virtually no central lumen (Figure 6). These mice were considerably smaller than normal (Figure 1B), had persistent diarrhea and rectal bleeding, and died prematurely from the first weeks of life to about 9 months maximum; all animals died with rectal prolapse. The effects were more pronounced in female, especially pregnant, mice than in males.
###end p 32
###begin title 33
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Massive colonic tumors in 3 month-old CEABAC20 mice.
###end title 33
###begin p 34
A) Cross sections of colon; note the much larger size of the CEABAC20 vs WT colons. B) Dramatic increase of colon mass and absence of fecal pellets in CEABAC20 over the entire colon. C) Colonic crypts; note the dramatic lengthening of intensely stained crypts in CEABAC20. Magnification: 40x (A), 100x (C). Staining: hematoxylin (A, C).
###end p 34
###begin p 35
###xml 166 174 166 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g007">Figure 7</xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Histological analysis of colonic mucosa from the 3 month-old CEABAC20 mice showed a non-focal continuous mosaic of severe hyperplasia, crypt serration and dysplasia (Figure 7). Dysplastic features included colonocyte stratification, displaced nuclei with prominent nucleoli and loss of polarization.
###end p 35
###begin title 36
Histopathological findings in CEABAC20 tumors including serrated adenomatous and dysplastic morphology.
###end title 36
###begin p 37
A) Longitudinal section of normal colonic crypts. B) Longitudinal sections of serrated colonic crypts showing upper third of the elongated crypts (left panel), sawtooth like in-folding at the mid-crypt (middle panel) and marked branching at the crypt base (right panel). C) Cross-section of a hyperplastic crypt (red arrow) showing numerous small mucinous vacuoles. D) Longitudinal section (left panel) and cross-section (right panel) of dysplastic crypts showing elongated nuclei and nuclear stratification (red arrow). There is also evidence of myofibroblastic (spindle cell) proliferation in the lamina propria in C and D. Magnification: 400x. Staining: hematoxylin and eosin.
###end p 37
###begin p 38
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Reddig1">[24]</xref>
###xml 594 603 594 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g008">Figure 8A</xref>
###xml 709 718 709 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g008">Figure 8B</xref>
###xml 1016 1033 1016 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g008">Figures 8C and 8D</xref>
###xml 1128 1132 1128 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Cory1">[32]</xref>
###xml 1202 1211 1202 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g008">Figure 8E</xref>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
A further change, characteristic of neoplasia, was the inhibition of anoikis, the apoptotic process that normally removes cells that are not properly anchored to the extra-cellular membrane and which therefore acts as a quality control mechanism for tissue architecture [24]. If the CEA/CEACAM6-mediated disruption of tissue architecture is to persist, this process needs to be inhibited. In fact, crypts from 3 month-old CEABAC20 mice often showed CEA/CEACAM6-positive anchorless cells in their lumens that were negative for staining by the TUNEL assay; such cells were not seen in WT crypts (Figure 8A). Moreover, protein extracts from CEABAC20 colonic mucosa showed less PARP cleavage than from WT mucosa (Figure 8B), suggesting that the proportion of cells undergoing apoptosis was less in the CEABAC20 mice than in WT mice. In addition, colonocytes purified from isolated crypts of even the reduced CEABAC dose CEABAC2 and CEABAC10 mice, when maintained in suspension, showed a dramatic reduction in apoptosis (Figures 8C and 8D). At the molecular level, the cleavage of caspase-3, which represents a hallmark of apoptosis [32], was also reduced in the suspended CEABAC2 and CEABAC10 colonocytes (Figure 8E).
###end p 38
###begin title 39
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Inhibition of apoptosis/anoikis in CEABAC mice.
###end title 39
###begin p 40
###xml 511 516 <span type="species:ncbi:10090">mouse</span>
###xml 1217 1221 <span type="species:ncbi:10090">mice</span>
A) TUNEL assays on formaldehyde-fixed frozen sections of WT and CEABAC20 colons. Cyan (red arrow): apoptotic nuclei; Blue (yellow arrow): non-apoptotic nuclei. Note the presence of non-apoptotic anchorless cells, which are CEA/CEACAM6-positive (data not shown), in the crypt lumens of CEABAC20 colons (yellow arrow). Magnification: 400x. Staining: DAPI. B) Immunoblots of colon protein extracts for PARP show reduced cleavage product of PARP (DeltaPARP) indicating an overall reduction of apoptosis in CEABAC20 mouse colons. C) TUNEL assays on purified colonocytes show a marked inhibition of anoikis of CEABAC colonocytes compared to WT colonocytes after 3 hours in single cell suspension. Negative control (freshly purified WT colonocytes) is completely TUNEL negative. Positive control (freshly purified WT colonocytes treated with DNAseI) is TUNEL positive. D) Apoptotic indices estimated from 3 independent experiments shown in C. E) Immunoblots of colonocyte lysates from anoikis experiment for caspase-3 show a baseline cleavage of caspase-3 (DeltaCaspase3) at time 0 (freshly purified colonocytes) and a marked reduction of caspase-3 cleavage at time 1 hr (after 1 hour in single cell suspensions) for CEABAC mice, indicating inhibition of anoikis in the CEABAC colonocytes.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 161 164 161 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Scholzel1">[4]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ilantzis2">[10]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Duxbury1">[12]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Stanners1">[33]</xref>
###xml 407 415 407 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 421 433 421 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 533 540 533 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1040 1048 1040 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1523 1528 1523 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">prior</italic>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 573 588 <span type="species:ncbi:10090">transgenic mice</span>
###xml 600 605 <span type="species:ncbi:9606">human</span>
###xml 637 642 <span type="species:ncbi:9606">human</span>
###xml 736 741 <span type="species:ncbi:9606">human</span>
###xml 806 811 <span type="species:ncbi:9606">human</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
The fact that CEA and/or CEACAM6 are over-expressed in so many human cancers has led us and others to suggest that this effect could contribute to tumorigenesis [4], [10], [12], [33]. However, the normally elevated expression of these molecules in differentiated epithelial cells presents a conundrum. Although evidence for tumorigenic effects of CEA and CEACAM6 has been documented in many diverse systems in vitro (see Introduction), the latter could be criticized for being model systems that fail to represent the real situation in vivo. This study, however, utilizing transgenic mice expressing human CEA and CEACAM6 genes with the human tissue specific pattern but with increasing expression levels to the point of those found in human carcinomas, represents perhaps the closest approximation to the human situation yet investigated. The results were striking in that purified colonocytes from these mice showed CEA/CEACAM6 expression level-dependent molecular changes involving integrin activation similar to those documented in the in vitro systems; tumorigenic cellular changes were observed such as increased proliferation and inhibition of differentiation and anoikis/apoptosis; and, finally, these cellular changes were mirrored by dramatic changes in colonic tissue architecture featuring severe hyperplasia and dysplasia, to the point of rendering the entire colon a massive tumor-like structure. The resolution of the above conundrum is suggested to be that elevated expression of CEA/CEACAM6 in colonocytes prior to their differentiation and loss of division potential is required for the manifestation of their tumorigenic effects.
###end p 42
###begin title 43
Molecular Basis of Tumorigenic Changes
###end title 43
###begin p 44
###xml 461 465 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ginsberg1">[34]</xref>
###xml 467 471 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Hynes1">[35]</xref>
###xml 655 659 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Park1">[36]</xref>
###xml 661 665 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Janes1">[37]</xref>
###xml 834 842 820 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 851 855 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Nicholson1">[19]</xref>
###xml 857 861 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-CamachoLeal1">[21]</xref>
###xml 863 867 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Duxbury2">[22]</xref>
###xml 869 873 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ordonez2">[38]</xref>
We suggest that the initial molecular events involved in these effects consist of CEA/CEACAM6-mediated clustering of membrane microdomains that specifically contain these adhesion molecules, integrin alpha5beta1, and a limited repertoire of cytoplasmic signaling elements, including ILK, PI3K and AKT. The co-clustering causes integrin alpha5beta1 to become activated, along with the PI3K/AKT pathway, by successive waves of inside-out and outside-in signaling [34], [35] resulting in inhibition of cell differentiation and anoikis and stimulation of cell proliferation-the latter previously documented by other groups to be caused by integrin activation [36], [37]; ultimately, tissue architecture is profoundly perturbed. Much of the evidence for this suggested model comes from detailed studies of the more experimentally amenable in vitro systems [19], [21], [22], [38] and the fact that these are mirrored by key changes in purified colonocytes from the CEABAC transgenics implies that it could apply in this situation too.
###end p 44
###begin p 45
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Rijkers1">[39]</xref>
The question arises as to whether these effects could have been due to a random insertional mutation of an endogenous gene rather than to direct effects of the elevated expression levels of CEA and CEACAM6. The former is unlikely, however, for the following reasons. First, random mutation of endogenous genes by transgenesis is an uncommon event [39]. Secondly, the probability of mutation of a gene resulting in an anticipated effect, i.e., specifically colorectal tumorigenesis, is even lower. Thirdly, to our knowledge, such dramatic tumorigenic effects have never been reported in any knockout models. Lastly and most importantly, both independently produced transgenic lines (CEABAC2 and CEABAC10), which would have different sites of integration, showed similar tumorigenic changes directly related quantitatively to expression level.
###end p 45
###begin p 46
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 297 300 297 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Hammarstrom1">[1]</xref>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Hammarstrom1">[1]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 533 541 533 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 572 575 572 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Eidelman1">[9]</xref>
###xml 576 580 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ordonez1">[15]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Leconte1">[40]</xref>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">both</italic>
###xml 679 686 679 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 756 760 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-EadesPerner1">[27]</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Thompson1">[29]</xref>
###xml 132 138 <span type="species:ncbi:9606">humans</span>
###xml 272 277 <span type="species:ncbi:9606">human</span>
###xml 559 564 <span type="species:ncbi:10090">mouse</span>
It is not clear from this work, however, which of the CEACAMs present in the CEABAC are responsible for these effects. Since, as in humans, CEACAM7 is expressed only at very low levels in these transgenics' colons [30] and is under-expressed rather than over-expressed in human colorectal cancers [1], and CEACAM3 is not at all expressed in the colon [1], [30], it seems very likely that CEA and/or CEACAM6 are responsible and, in fact, both of the latter genes have been shown to elicit tumorigenic effects in various model systems in vitro and in xenograft mouse models [9]-[15], [40]. It is possible that over-expression of both CEA and CEACAM6 are required for these effects in vivo, which would explain the failure to see them in CEA-only transgenics [27]-[29], although it is equally possible that the CEA colonocyte expression levels in the latter were too low or that the CEACAM6 expression is the key determinant.
###end p 46
###begin p 47
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Taheri1">[18]</xref>
###xml 666 670 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Taheri1">[18]</xref>
###xml 672 676 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-CamachoLeal1">[21]</xref>
###xml 1272 1276 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan2">[41]</xref>
###xml 1067 1071 <span type="species:ncbi:10090">mice</span>
###xml 1121 1125 <span type="species:ncbi:10090">mice</span>
###xml 1267 1271 <span type="species:ncbi:10090">mice</span>
With the likely assumption that the effects are due to CEA and CEACAM6, clustering of these molecules as their concentration increases by self-binding of their adhesive external domains [18] is suggested to be the initial event leading to the changes in cellular state observed here. This suggestion is supported by previous work with several cell lines expressing a CEA mutant that is defective in self-binding. None of the molecular events, including integrin alpha5beta1 activation, or the cellular events, including inhibition of differentiation were produced by this mutant, but all these events were promptly restored by cross-linking with specific antibodies [18], [21]. In this study, the tumorigenic effects were strongly gene dose dependent, which would be expected if they depended on self-binding and clustering, which would be a positive power function (at least a square function) of cell surface molecular concentration. This was most apparent in the case of the disruption of colonic tissue architecture, which was extreme in the case of the CEABAC20 mice. It is of interest that the CEABAC2 and CEABAC10 mice, which showed more moderate colonic changes, were nevertheless much more prone to produce carcinogen-induced focal colorectal tumors than WT mice [41].
###end p 47
###begin p 48
###xml 85 93 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 399 407 381 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 547 551 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Caswell1">[42]</xref>
###xml 553 557 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Bretscher1">[43]</xref>
###xml 765 770 <span type="species:ncbi:10090">mouse</span>
Evidence for the involvement of integrin alpha5beta1 activation, previously shown in in vitro systems, was obtained in the observation of a CEABAC dose-dependent increase in the colonocyte surface concentration of this integrin relative to WT littermates and integrin alpha2 surface concentration. We speculate that this increase is due to an initial activation of integrin alpha5beta1, as observed in vitro, followed by an increase in cell surface level, a positive feedback control loop previously documented for integrins in many other systems [42], [43]. If so, it could imply that the colonocyte integrin alpha5beta1 molecules are not only increased in number but also in activation state, although this would obviously require direct confirmation. The CEABAC mouse colonocytes showed evidence for the activation of AKT but, in preliminary experiments, no evidence for activation of the Wnt-signaling pathway could be demonstrated, in that no nuclear accumulation of beta-catenin was seen (Chan and Stanners, unpublished data).
###end p 48
###begin title 49
###xml 13 18 <span type="species:ncbi:9606">Human</span>
Relevance to Human Colon Carcinogenesis
###end title 49
###begin p 50
###xml 348 357 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g006">Figures 6</xref>
###xml 362 363 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001353-g007">7</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Screaton1">[16]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan2">[41]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Screaton1">[16]</xref>
###xml 955 959 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Velcich1">[44]</xref>
###xml 1337 1341 1337 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan2">[41]</xref>
###xml 2327 2331 2327 2331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan2">[41]</xref>
###xml 2701 2705 2701 2705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Screaton1">[16]</xref>
###xml 2918 2921 2918 2921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Hammarstrom1">[1]</xref>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 515 518 <span type="species:ncbi:10116">rat</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 822 827 <span type="species:ncbi:10090">mouse</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
###xml 1252 1256 <span type="species:ncbi:10090">mice</span>
###xml 1359 1363 <span type="species:ncbi:10090">mice</span>
###xml 1760 1764 <span type="species:ncbi:10090">mice</span>
###xml 1992 1997 <span type="species:ncbi:9606">human</span>
###xml 2186 2191 <span type="species:ncbi:9606">human</span>
###xml 2322 2326 <span type="species:ncbi:10090">mice</span>
###xml 2873 2878 <span type="species:ncbi:9606">human</span>
The most striking and unexpected feature of the present results is first, the magnitude of the effects, which are arguably greater than those seen for any single oncogene or inactivated tumor suppressor gene expressed in animals and second, the fact that this tumorigenic phenotype involves the entire colon in a diffuse mosaic pattern of changes (Figures 6 and 7) in 100% of the CEABAC20 mice. CEA, and possibly CEACAM6, over-expression has been shown to be mutagenic [16], [41], leading to the rapid outgrowth of rat L6 tumors with a dramatically reduced latent period, reduced even more than that observed with the expression of a combination of v-myc and Bcl2 [16]. If random mutations were required in the CEABAC20 mice, however, the neoplastic changes observed would be focal, as is the case for all other published mouse models with tumorigenic genetic alterations. The present case may bear some resemblance to that of mucin Muc2 deletion in mice [44], in which relatively small non-focal increases in proliferation and decreases in apoptosis were observed in the entire gastrointestinal tract; in this case, focal carcinomas appeared later in life, presumably due to secondary mutations. This is actually the case for the CEABAC2 and CEABAC10 mice which showed a marked increase in focal carcinomas after azoxymethane treatment [41]. In the CEABAC20 mice, on the other hand, the expression level of CEA and CEACAM6 is high enough to drive the abnormal growth of colonic crypts demonstrated by the extreme cellular changes within a given crypt. This abnormal and uncontrolled growth pattern leads to a complete disruption of normal tissue architecture and a large increase in crypt length. In fact these primary changes are so dramatic in the CEABAC20 mice that any focal carcinomas would likely have little selective growth advantage and, in any case, the animals tend to die from digestive complications before about 6 months of age, thus not allowing a long term assessment. Since human colonic tumorigenesis is in fact focal, we suggest that, unlike the situation here where every cell has multiple copies of CEA and CEACAM6 genes, their over-expression itself in the adult human colon could occur by focal up-regulation in expression as observed in the carcinogen-induced colon tumors in CEABAC2 and CEABAC10 mice [41]. We therefore propose that the increase in proliferation and inhibition of differentiation and anoikis together with the disruption of tissue architecture, induced by CEA/CEACAM6 over-expression in colonocytes, puts them in a state that is more susceptible to effects of other oncogenic lesions, thus representing a significant contribution to malignant transformation [16]. Note that this model does not require structural mutations in CEA or CEACAM6 themselves and, in fact, such mutations are generally not observed in cDNAs derived from human tumors over-expressing these molecules [1].
###end p 50
###begin p 51
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Goldstein1">[45]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Jass1">[46]</xref>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Jass2">[47]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Baker1">[48]</xref>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Giles1">[49]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Kinzler1">[50]</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Jass1">[46]</xref>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
###xml 793 798 <span type="species:ncbi:9606">human</span>
Another interesting feature of these tumors was their resemblance to mixed hyperplastic polyps, serrated polyps and serrated adenomas in human patients, which are subtypes of pre-cancerous lesions [45], [46] that show increased expression of CEA [47], [48]. In contrast to conventional adenomas in which perturbation of the Wnt-signaling pathway is commonly believed as the initiating event [49], [50], this serration is a consequence of alteration in cell proliferation and apoptosis leading to inactivation of DNA repair genes by promoter methylation and secondary mutations that cause tumor progression [46]. Based on the proliferative and anti-apoptotic effects of CEA/CEACAM6 shown in the CEABAC mice, it is thus possible that this could represent the first animal model for this type of human colorectal neoplasia.
###end p 51
###begin p 52
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dead-end</italic>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Jass1">[46]</xref>
###xml 957 961 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Screaton1">[16]</xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
However, the non-focal concomitant dysplasia observed in the CEABAC20 mice requires comment. The traditional view is that hyperplasia is a dead-end state that does not progress to dysplasia. Although the serrated pathway allows such a transition, only a small proportion of hyperplastic lesions transform to dysplastic serrated adenomas after acquiring other gene mutations, such as hMLH1 or MGMT [46]. The rather frequent non-focal transition to colonic tissue with features of dysplasia observed in CEABAC20 mice suggests that over-expression of CEA and/or CEACAM6 to a critical threshold level alone is sufficient to initiate the transformation of a normal epithelium to a state of dysplasia. It thus appears that homotypic adhesion molecules with their self-binding external domains can effect this by clustering without the need for mutations, either in themselves or in other elements. Secondary mutations [whose incidence is stimulated by this state [16]], however, would be required to ensure rigorous heritability.
###end p 52
###begin title 53
###xml 17 22 <span type="species:ncbi:9606">Human</span>
Significance for Human Cancer
###end title 53
###begin p 54
###xml 160 163 160 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Scholzel1">[4]</xref>
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Ilantzis1">[8]</xref>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Pretlow1">[51]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Wirth1">[13]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Soeth1">[14]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Duxbury3">[52]</xref>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Duxbury4">[53]</xref>
###xml 758 770 758 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">declustering</italic>
###xml 778 782 778 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Taheri1">[18]</xref>
###xml 40 45 <span type="species:ncbi:9606">human</span>
If these results can be extrapolated to human colorectal cancer, in which up-regulation of CEA and CEACAM6 occurs as an early event in adult colonic epithelium [4], [8], [51], the magnitude of the tumorigenic effects observed here would imply a very significant contribution to the malignant phenotype. Thus, clinically, cancer treatments should aim to reduce their levels and should not further up-regulate them to enhance tumor targeting. Perhaps more importantly, strategies designed to reverse their biological effects rather than to use them as inert targets should be considered. In fact, reduction of their expression has been shown to reverse some tumor phenotypes [13], [14], [52] and to restore sensitivity to chemotherapeutic agents [53], as have declustering agents [18]. Thus, development of agents that inhibit expression and function of these proteins could prove beneficial to clinical practice.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
Animals
###end title 56
###begin p 57
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 406 413 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 7 22 <span type="species:ncbi:10090">transgenic mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 358 373 <span type="species:ncbi:10090">transgenic mice</span>
CEABAC transgenic mice (CEABAC2 and CEABAC10 lines, bearing 2 and 10 copies of the CEABAC transgene, respectively) were produced and maintained on the FVB strain background. Genotypes of mice were determined by PCR as described elsewhere [30]. CEABAC20 mice (bearing 20 copies of the CEABAC transgene) were produced from mating two CEABAC10 mice. Homozygous transgenic mice were identified by fluorescence in situ hybridization of the CEABAC in splenocytes (see below).
###end p 57
###begin title 58
Antibodies
###end title 58
###begin p 59
###xml 923 927 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Zhou1">[54]</xref>
###xml 1052 1055 1041 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Scholzel1">[4]</xref>
###xml 0 6 <span type="species:ncbi:9986">Rabbit</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 748 753 <span type="species:ncbi:10090">Mouse</span>
Rabbit polyclonal antibodies (Ab) used were: anti-CEA Ab (RbalphaCEA) which recognizes all human CEACAM family members; anti-integrin alpha5 Ab (H-104), anti-integrin beta1 Ab (M-106) and anti-PARP Ab (H-250) which detects the C-terminus of PARP-1 and PARP-2 (Santa Cruz Biotechnology Inc., Santa Cruz, CA); anti-FAK Ab (Upstate Cell Signaling, Charlottesville, VA); anti-Akt Ab which detects the total level of Akt1, Akt2 and Akt3, anti-Phospho-Akt (Ser473) Ab which detects Akt1 only when phosphorylated at the Ser473 residue and also Akt2 and Akt3 when phosphorylated at the corresponding residues, anti-caspase-3 Ab which detects full length caspase-3 and the large fragment of cleaved caspase-3 (Cell Signaling Technology Inc., Beverley, MA). Mouse monoclonal antibodies (mAb) used were: anti-CEA mAb (J22 and A20) which recognize the internal domains of CEA and CEACAM6 and the N-terminal domain of CEA, respectively [54]; anti-CEA mAb (T84.66) which recognizes only CEA (ATCC, Manassas, VA); anti-CEACAM6 mAb (9A6) which recognizes only CEACAM6 [4]; anti-ILK mAb (BD Biosciences, Mississauga, Canada); and anti-PCNA mAb (PC10) (DAKO Diagnostics Canada Inc., Mississauga, Canada). Hamster monoclonal antibodies used are: anti-integrin alpha5 mAb (HMalpha5-1) (BD Biosciences) and anti-integrin alpha2 mAb (HMalpha2) (Chemicon International Inc., Temecula, CA).
###end p 59
###begin title 60
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Situ</italic>
Fluorescence In Situ Hybridization and TUNEL Assay
###end title 60
###begin p 61
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Spector1">[55]</xref>
For fluorescence in situ hybridization (FISH), freshly isolated splenocytes were treated as previously described [55]; DIG-labeled CEA cDNA probes were generated using the High Prime DNA Labeling Kit (Roche Diagnostics Inc., Laval, Canada), and detection was performed using the Fluorescent Antibody Enhancer Set for DIG Detection (Roche Diagnostics Inc.). The terminal deoxynucleotidyl transferase (TdT)-mediated dUTP Nick-End-Labeling (TUNEL) assay was used to detect apoptotic cells according to the protocol provided by the APOAlerttrade mark DNA Fragmentation Assay Kit (BD Biosciences). Fluorescent cells were visualized using a fluorescent light microscope.
###end p 61
###begin title 62
###xml 13 18 <span type="species:ncbi:10090">Mouse</span>
Isolation of Mouse Colonic Epithelial Cells
###end title 62
###begin p 63
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Grossmann1">[56]</xref>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
Colonic epithelial cells were isolated from mice using a protocol modified from one previously described for human samples [56]. Briefly, 6 intact mouse colons were flipped inside-out and incubated for 30 minutes in a 1.3 mM DTT/PBS solution at room temperature and then 10 minutes in a 1.5 mM EDTA/PBS solution at 37degreesC. Intact colonic crypts were separated from the underlying layers by vigorous shaking, collected using a 40-microm nylon cell strainer (BD Biosciences) and treated with dispase (1.2 mg/ml) for 10 minutes to give a single-cell suspension.
###end p 63
###begin title 64
Detection of cell surface levels of CEA, CEACAM6 and integrins
###end title 64
###begin p 65
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan2">[41]</xref>
Cell surface levels of CEA, CEACAM6 and integrins on purified colonic epithelial cells were determined by fluorescence-activated cell sorting (FACS) analysis, as described elsewhere [41], using T84.66, 9A6, HMalpha5-1, and HMalpha2 Abs.
###end p 65
###begin title 66
Anoikis Assay for Purified Colonic Epithelial Cells
###end title 66
###begin p 67
Single cell suspensions of purified colonocytes were incubated in suspension in serum-free DMEM medium for 1 or 3 hours at 37degreesC. The extent of apoptosis was assessed by immunoblot analysis of caspase-3 cleavage after 1 hour (see below) and by the TUNEL assay after 3 hours (see above). Baseline apoptosis was determined immediately after purification. For a positive control of the TUNEL assay, cells were pre-treated with DNAse I (1 microg/ml). For a negative control, TdT was omitted in the TUNEL reaction. Apoptotic index was expressed as a percentage of apoptotic cells over the total number of cells counted.
###end p 67
###begin title 68
Isolation of Membrane Rafts
###end title 68
###begin p 69
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-CamachoLeal1">[21]</xref>
Membrane rafts were isolated from 5-10 x 106 purified colonic epithelial cells by isopycnic sucrose density gradient centrifugation; membrane raft-containing fractions were identified by the presence of GM1 using dot-blots, as described previously [21].
###end p 69
###begin title 70
Immunoblot analysis
###end title 70
###begin p 71
###xml 471 472 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 659 663 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-CamachoLeal1">[21]</xref>
Crude colonic tissue extracts were obtained by scraping colonic mucosa away from the underlying layers, homogenizing with PBS on ice and lysing with SDS lysis buffer (100 mM Tris pH 8, 10% glycerol, 2% SDS). Colonic epithelial extracts were obtained by lysis of purified colonic epithelial cells (see above for isolation) in RIPA lysis buffer (20 mM Tris-HCl pH 8, 140 mM NaCl, 2 mM EDTA pH 8, 10 microg/ml aprotinin, 10 microg/ml leupeptin, 100 microg/ml PMSF, 1 mM NaVO3, 10 mM NaF). Proteins from crude colonic tissue extracts, purified colonic epithelial extracts or sucrose gradient fractions were detected by immunoblot analyses, as described elsewhere [21].
###end p 71
###begin title 72
Histological analysis and immunohistochemistry
###end title 72
###begin p 73
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Lynch1">[57]</xref>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Lynch1">[57]</xref>
###xml 810 814 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001353-Chan1">[30]</xref>
###xml 880 885 <span type="species:ncbi:10090">mouse</span>
For cryosection, freshly collected tissues were fixed with 4% paraformaldehyde and processed as described elsewhere [30]. For paraffin-embedded sections, freshly excised tissues were fixed in Glyo-Fixx (20% ethanol, 5% glyoxal, 1% propanol and 1% methanol) for 48 hours at room temperature and processed for embedding in paraffin blocks for sectioning. For general histopathology, frozen sections were stained with hematoxylin and paraffin-embedded sections were stained with hematoxylin and eosin [57]. To assess colonocyte differentiation, frozen sections were stained by the "alcian blue-periodic acid Schiff" method to detect mucin, followed by methyl green staining to detect nuclei (AB-PAS-MG) [57]. For immunohistochemistry, frozen sections were probed with RbalphaCEA antibodies as described elsewhere [30]. Actively proliferating cells were detected using HRP-conjugated mouse monoclonal anti-PCNA antibody.
###end p 73
###begin title 74
Differentiation and Proliferation Analyses
###end title 74
###begin p 75
For differentiation and proliferation analyses, animals were sacrificed at exactly postnatal day 21 to minimize growth variation. Percent crypt fission was scored as the percentage of forked dividing crypts over the total number of crypt bases for about 100 crypts. Proliferation index was scored as the number of PCNA-positive nuclei divided by total number of nuclei in about 10 individual crypts. The level of differentiation was scored as the number of large goblet cells (mucin vacuole of more than 10 microm) over the total number of crypt bases for about 100 crypts.
###end p 75
###begin title 76
References
###end title 76
###begin article-title 77
###xml 33 38 <span type="species:ncbi:9606">human</span>
The nature and expression of the human CEA family.
###end article-title 77
###begin article-title 78
CEA in tumors of other than colorectal origin.
###end article-title 78
###begin article-title 79
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
###end article-title 79
###begin article-title 80
Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas.
###end article-title 80
###begin article-title 81
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Carcinoembryonic antigen in staging and follow-up of patients with solid tumors.
###end article-title 81
###begin article-title 82
Carcinoembryonic antigen: cell adhesion molecule and useful diagnostic marker.
###end article-title 82
###begin article-title 83
Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.
###end article-title 83
###begin article-title 84
###xml 23 28 <span type="species:ncbi:9606">human</span>
Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis.
###end article-title 84
###begin article-title 85
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 105 108 <span type="species:ncbi:10116">rat</span>
Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts.
###end article-title 85
###begin article-title 86
###xml 30 35 <span type="species:ncbi:9606">human</span>
Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation.
###end article-title 86
###begin article-title 87
###xml 67 72 <span type="species:ncbi:9606">human</span>
Radical differences in functions of closely related members of the human carcinoembryonic antigen gene family.
###end article-title 87
###begin article-title 88
CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
###end article-title 88
###begin article-title 89
Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth.
###end article-title 89
###begin article-title 90
Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells.
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human carcinoembryonic antigen functions as a general inhibitor of anoikis.
###end article-title 91
###begin article-title 92
###xml 28 33 <span type="species:ncbi:9606">human</span>
Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation.
###end article-title 92
###begin article-title 93
The specificity for the differentiation blocking activity of carcinoembryonic antigen resides in its glycophosphatidyl-inositol anchor.
###end article-title 93
###begin article-title 94
The adhesion and differentiation-inhibitory activities of the immunoglobulin superfamily member, carcinoembryonic antigen, can be independently blocked.
###end article-title 94
###begin article-title 95
Specific inhibition of GPI-anchored protein function by homing and self-association of specific GPI anchors.
###end article-title 95
###begin article-title 96
Integrin signaling.
###end article-title 96
###begin article-title 97
###xml 96 101 <span type="species:ncbi:9606">human</span>
A co-clustering model involving alpha5beta1 integrin for the biological effects of GPI-anchored human Carcinoembryonic Antigen (CEA).
###end article-title 97
###begin article-title 98
c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
###end article-title 98
###begin article-title 99
Get a ligand, get a life: integrins, signaling and cell survival.
###end article-title 99
###begin article-title 100
Clinging to life: cell to matrix adhesion and cell survival.
###end article-title 100
###begin article-title 101
Integrin signalling during tumour progression.
###end article-title 101
###begin article-title 102
The nature and expression of the rodent CEA families: Evolutionary considerations.
###end article-title 102
###begin article-title 103
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 24 29 <span type="species:ncbi:9606">human</span>
Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern.
###end article-title 103
###begin article-title 104
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 20 25 <span type="species:ncbi:9606">human</span>
Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy.
###end article-title 104
###begin article-title 105
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy.
###end article-title 105
###begin article-title 106
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
Novel mouse model for carcinoembryonic antigen-based therapy.
###end article-title 106
###begin article-title 107
###xml 135 138 <span type="species:ncbi:10116">rat</span>
Differences in the effects of age on intestinal proliferation, crypt fission and apoptosis on the small intestine and the colon of the rat.
###end article-title 107
###begin article-title 108
The Bcl2 family: regulators of the cellular life-or-death switch.
###end article-title 108
###begin article-title 109
###xml 21 26 <span type="species:ncbi:9606">human</span>
Contributions of the human CEA family to malignant transformation.
###end article-title 109
###begin article-title 110
Integrin regulation.
###end article-title 110
###begin article-title 111
Integrins: bidirectional, allosteric signaling machines.
###end article-title 111
###begin article-title 112
Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.
###end article-title 112
###begin article-title 113
New roles for integrins in squamous-cell carcinoma.
###end article-title 113
###begin article-title 114
GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin alpha5beta1-fibronectin interaction.
###end article-title 114
###begin article-title 115
###xml 27 42 <span type="species:ncbi:10090">transgenic mice</span>
Insertional mutagenesis in transgenic mice.
###end article-title 115
###begin article-title 116
Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model.
###end article-title 116
###begin article-title 117
###xml 68 83 <span type="species:ncbi:10090">transgenic mice</span>
Increased colon tumor susceptibility in azoxymethane treated CEABAC transgenic mice.
###end article-title 117
###begin article-title 118
Integrin trafficking and the control of cell migration.
###end article-title 118
###begin article-title 119
Circulating integrins: alpha 5 beta 1, alpha 6 beta 4 and Mac-1, but not alpha 3 beta 1, alpha 4 beta 1 or LFA-1.
###end article-title 119
###begin article-title 120
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Colorectal cancer in mice genetically deficient in the mucin Muc2.
###end article-title 120
###begin article-title 121
Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification.
###end article-title 121
###begin article-title 122
Emerging concepts in colorectal neoplasia.
###end article-title 122
###begin article-title 123
A morphologic and histochemical study of metaplastic polyps of the colorectum.
###end article-title 123
###begin article-title 124
Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?
###end article-title 124
###begin article-title 125
Caught up in a Wnt storm: Wnt signaling in cancer.
###end article-title 125
###begin article-title 126
Lessons from hereditary colorectal cancer.
###end article-title 126
###begin article-title 127
###xml 28 33 <span type="species:ncbi:9606">human</span>
Carcinoembryonic antigen in human colonic aberrant crypt foci.
###end article-title 127
###begin article-title 128
Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
###end article-title 128
###begin article-title 129
A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
###end article-title 129
###begin article-title 130
Specificity of anti-carcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion.
###end article-title 130
###begin article-title 131
Cells: A Laboratory Manual.
###end article-title 131
###begin article-title 132
###xml 93 98 <span type="species:ncbi:9606">human</span>
Apoptotic signaling during initiation of detachment-induced apoptosis ("anoikis") of primary human intestinal epithelial cells.
###end article-title 132
###begin article-title 133
Medical Laboratory Technology and Clinical Pathology.
###end article-title 133
###begin p 134
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 134
###begin p 135
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the National Cancer Institute of Canada with funds from the Canadian Cancer Society, and by the Canadian Institutes of Health Research. CHFC was supported by a MD/PhD studentship from the Canadian Institutes of Health Research. PC was supported by a studentship from the National Science Council (CONACYT) of Mexico.
###end p 135

